Economic damage from infectious diseases in Russia over $18 bln in 2025 The treatment of acute upper respiratory tract infections of multiple and unspecified localization required the largest amount of investments. This information was released by the Russian Federal Service for Oversight of Consumer Protection and Welfare. This indicates a significant financial burden associated with common respiratory illnesses in Russia.

• Treatment of acute upper respiratory tract infections of multiple and unspecified localization required the largest investments.
• The Russian Federal Service for Oversight of Consumer Protection and Welfare provided this information.